Area of research
Immunology · Hematology
Research interest
Research focused on ADAMTS13 and Thrombotic thrombocytopenic purpura, with related work in Autoantibody, Exacerbation, Rituximab. Notable publications include 'Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study', 'Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH', and 'Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura'.
100 Jahre Thrombotisch-thrombozytopenische Purpura (TTP) – Was haben wir gelernt?
Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura
Open ADAMTS-13 conformation index predicts earlier relapse in immune-mediated thrombotic thrombocytopenic purpura
A novel von Willebrand factor multimer ratio as marker of disease activity in thrombotic thrombocytopenic purpura
Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH
Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpura
Erratum: Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura
ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP
Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura
Immunogenic hotspots in the spacer domain of ADAMTS13 in immune‐mediated thrombotic thrombocytopenic purpura
CD36‐fibrin interaction propagates FXI‐dependent thrombin generation of human platelets
Relapse Rate in Survivors of Acute Autoimmune Thrombotic Thrombocytopenic Purpura Treated with or without Rituximab
Depression and cognitive deficits as long‐term consequences of thrombotic thrombocytopenic purpura
Current insights into thrombotic microangiopathies: Thrombotic thrombocytopenic purpura and pregnancy
Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study